Clinical evaluation of genetically engineered hypoallergenic rBet v 1 derivatives

Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):216-7. doi: 10.1159/000024074.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allergens / genetics
  • Allergens / immunology*
  • Allergens / therapeutic use
  • Antigens, Plant
  • Desensitization, Immunologic*
  • Genetic Engineering
  • Humans
  • Hypersensitivity / drug therapy*
  • Hypersensitivity / immunology
  • Plant Proteins / genetics
  • Plant Proteins / immunology*
  • Plant Proteins / therapeutic use
  • Recombinant Proteins / genetics
  • Recombinant Proteins / immunology
  • Recombinant Proteins / therapeutic use

Substances

  • Allergens
  • Antigens, Plant
  • Plant Proteins
  • Recombinant Proteins
  • Bet v 1 allergen, Betula